Government Accepts Stillbirth Recommendations

[vc_row][vc_column][vc_column_text]In Australia, about 6 babies are stillborn every day, and two die in the neonatal period within 28 days of birth, due to congenital anomalies which account for almost a third of all perinatal deaths.

Rates of perinatal death have remained relatively constant since 1997. Rates of stillbirths among Indigenous women, while decreasing, are still at an alarming rate compared to other demographics.

Last year Labor Senator for NSW, Kristina Keneally, was moved to tears when discussing the Stillbirth Research and Education Report, which she said would be “part of the legacy” of those children who had been lost and their brave parents who had to endure that loss.

Australian Institute of Health and Welfare (AIHW) spokesperson, Dr Fadwa Al-Yaman, said ongoing monitoring of perinatal deaths could help build the evidence-base to drive better outcomes.

“The report provides valuable information to enable effective policy, practice and services for mothers and babies,” Dr Al-Yaman said.

The AIHW said it was also working to improve the quality of data around the contributing factors to stillbirths.

Minister for Health, Greg Hunt, said reducing the rate of stillbirth in Australia, including providing the best possible support services for families living with the tragedy of stillbirth, is a priority for the Morrison Government.

“We understand the importance of this issues not only for the women affected, but for their partners, families and the broader community,” Mr Hunt said.

Red Nose Australia CEO, Keren Ludski, welcomed the Government’s funding announcement and commended the Government for accepting all recommendations in the Senate Select Committee on Stillbirth Research and Education Report.

“The stillbirth rate in Australia is six a day – that’s one baby every four hours. Enough is enough – it’s time we made reducing stillbirth a national priority,” Ms Ludski said.

“Red Nose Day on Friday 9 August will have a significant focus on raising awareness and funds for stillbirth research, with a goal of reducing stillbirth by 20 per cent over the next three years – equalling 500 little lives saved, and I urge all Australians to get involved by buying a red nose or making a donation,” she said.

The recommendations accepted by the Federal Government include:

  • Developing a National Stillbirth Action and Implementation Plan
  • Investing in stillbirth research
  • Developing best practice and culturally appropriate resources, and
  • Working with States and Territories to make improvements in key areas including improving national perinatal mortality data collections, improving access to publicly funded stillbirth autopsies, building the perinatal pathology workforce, developing more culturally and linguistically appropriate models of care, bereavement support and protocols for public hospitals and community health services.

You can download the Federal Government’s response to the Stillbirth Research and Education Report here.[/vc_column_text][/vc_column][/vc_row]

NSW Health On-Line Vaccine Care Training Module

How it works:

All General Practitioners must ensure at least one staff member has taken the NSW Health on-line vaccine care training module.

NSW Health will be working with the Royal Australian College of General Practitioners, the Australian Medical Association, the Medical Council of NSW, and the Primary Health Networks to assist in reminding GPs of their vaccine care obligations.

Why it matters:

The Medical Council of NSW and the NSW Health Care Complaints Commission are investigating and responding to incidents of patients that have been vaccinated with improperly kept vaccines.

Ask the expert:

Dr Kerry Chant, NSW Chief Medical Officer

“While NSW Health does not have responsibility for GPs, we are working with GPs and assisting co-regulators to ensure patients are correctly and effectively vaccinated.”

“Vaccines need to be stored at an optimal temperature range to ensure patients are protected from illness such as the flu, measles, or meningococcal disease.”

The details:

The free vaccine cold chain management online learning module is available at https://www.health.nsw.gov.au/immunisation/Pages/cold-chain-management.aspx

MTANZ WARNS OF IMPACT OF MEDICAL DEVICE REGULATION CHANGES ON PATIENTS

[vc_row][vc_column][vc_column_text]MTANZ CEO, Faye Sumner, said the “proposed Therapeutic Products Bill and the ongoing centralised procurement process by PHARMAC could have the joint effect of increasing the costs of medical devices and procedures while potentially reducing choice for the clinician and delaying access to life-saving, innovative medical technology.”

MTANZ has assured patients that medical devices used in New Zealand currently meet the highest quality standards both in New Zealand and internationally.

Currently, all devices entering New Zealand must be notified to the Government’s regulator, Medsafe. However, MTANZ argues that this will become a more complex registration process with associated costs, under the proposed NZ Therapeutic Products legislation replacing the Medicines Act 1981.

At the same time, PHARMAC is taking control of the procurement of medical devices supplied to the District Health Boards.

Ms Sumner says the New Zealand MedTech industry believes the proposed PHARMAC cost-based procurement system is not best suited to the procurement of medical devices.

“We propose a value-based procurement system that ensures clinicians have the autonomy and authority to acquire the right device for the right procedure. It is about treating a patient with the best possible device rather than the cheapest possible device.

“Our industry is very concerned at the multiplying effect of both significant changes being introduced in parallel and the potential disruption to the supply chain which could lead to the reduced availability of medical device products in the New Zealand market,” Ms Sumner said.

Ultimately the impact of both these changes will be felt by New Zealand patients.

These changes will no doubt be watched very closely by both the Australian MedTech companies and Private Health Insurers.

The Australian Private Health Insurance industry has been advocating for the introduction of a similar national procurement system here in Australia.[/vc_column_text][/vc_column][/vc_row]

ZIMMER BIOMET AND APPLE COLLABORATION

This collaboration has yielded Zimmer Biomet mymobility™, an app that uses Apple Watch to facilitate a new level of connection between patients and their surgical care teams, which can immediately impact the journey patients experience when they undergo these procedures.

In addition to the app, Zimmer Biomet commenced the mymobility Clinical Study in October last year, designed to study the app’s impact on patient outcomes and overall costs for joint replacement patients.

During this research study, patients are using Zimmer Biomet mymobility with Apple Watch as they progress through their hip or knee replacement journey. Researchers combine patient-reported feedback with continuous health and activity data from Apple Watch to provide new insights into the power of the Zimmer Biomet mymobility app to impact the standard of care for these common surgeries. The study launched in October 2018 for patients based in the US.

“We are incredibly excited to work with Apple to transform the knee and hip replacement experience for patients and surgeons,” said Bryan Hanson, President and CEO, Zimmer Biomet. “At Zimmer Biomet, we are committed to improving care decisions through digital health and we are thrilled to launch one of the largest evidence-gathering clinical studies in orthopaedic history.”

“We believe one of the best ways to empower consumers is by giving them the ability to use their health and activity information to improve their own care,” said Jeff Williams, Chief Operating Officer, Apple. “We are proud to enable knee and hip replacement patients to use their own data and share it with their doctors seamlessly, so that they can participate in their care and recovery in a way not previously possible through traditional in-person visits. This solution will connect consumers with their doctors continuously, before and after surgery.”

More than one million knee and hip replacements occur annually in the U.S. This number is expected to grow to 3.5 million by 2035, yet standardization of care and recovery for the procedures is still lacking and costs to the U.S. healthcare system continue to rise. Zimmer Biomet mymobility and Apple Watch will act as a virtual and continuous care team on a patient’s wrist. Patients will be provided with support and guidance as they prepare for and recover from these surgeries, while surgeons will be delivered continuous data to optimize care.

The new Zimmer Biomet mymobility app has several features that use both Apple Watch and iPhone through the joint replacement journey, including the ability for surgeons to send education and therapy reminders directly to the patient’s Apple Watch.

The app also allows surgeons to monitor patient activity levels throughout the days and weeks while they are preparing for and recovering from surgery.

Shaking up value-based health care: how and why it can work in Australia

[vc_row][vc_column][vc_column_text]In launching its Australian Centre for Value-Based Health Care and two issues briefs which explore definitions and funding options, the AHHA highlights work being undertaken by its members and partners as they seek to maximise value in health care and build on work being led by Commonwealth, state and territory governments to move the focus in health policy from volume to value.

Health systems around the world have been exploring how to move the focus of their activities from delivering volume to delivering value. In doing so, they are trying to re-orient health service delivery to provide improved patient outcomes, often while reducing the overall cost of delivery.

To lay the foundation for what value-based health care means in Australia, the Centre’s first paper considers Australia’s alignment with a value-based approach and identifies important enablers that must be part of a coordinated national strategy.

To enable value-based health care through public policy in Australia, Value based health care: setting the scene for Australia by AHHA Policy Director Kylie Woolcock recommends a national, cross-sector strategy for value-based health care in Australia supported by: access to relevant and up-to-date data; evidence for value-based health care in the Australian context; a health workforce strategy supporting models of care that embrace a value-based approach; and funding systems that incentivise value.

Team-based care models with professionals working at the top of their licence may offer more effective, timelier and better value care than traditional care systems.

Funding arrangements need to move away from a reliance on traditional fee-for-service models, which can entrench fragmented care. Rewards and funding should be re-oriented to what matters to patients, namely health outcomes and ongoing effective management of chronic conditions.

Re-orienting funding from volume to value in public dental health services by Dental Health Services Victoria’s Dr Shalika Hegde outlines how they became the first organisation in Australia to implement a patient-centric, and outcomes and prevention focused value-based health care model in the public dental sector using existing funding.

“Dr Hegde argues for strong national leadership and the cooperation of all jurisdictions to implement a national public dental funding system focused on value and outcomes—which will benefit all parties,” said Ms Verhoeven,

“This is not about saving money—this is about achieving better outcomes that matter to patients and getting better value for every public dollar spent.

“We invite innovative organisations from around Australia to partner with us to go on the value-based health care journey.”

Visit the Australian Centre for Value-Based Health Care at www.valuebasedcareaustralia.com.au. To find out more about the AHHA, visit www.ahha.asn.au.

The Australian Centre for Value-Based Health Care is the nexus of the value-based health care movement in Australia, bringing together educational and training opportunities, quality research and best practice case studies into a hub where those interested in value-based health care can easily find resources.[/vc_column_text][vc_zigzag][/vc_column][/vc_row][vc_row][vc_column width=”1/4″][vc_single_image image=”1850″ img_size=”full”][/vc_column][vc_column width=”3/4″][vc_column_text]You may also be interested in reading:

VALUE-BASED HEALTHCARE IN AUSTRALIA
by Andrew Wiltshire

[/vc_column_text][/vc_column][/vc_row]

Breakthrough Link For Parkinson and MND Sufferers

[vc_row][vc_column][vc_column_text]

Facts and figures:

Researchers chose 19 patients for the trial, who were assigned to three different dose cohorts throughout six, 28-day cycle periods. Those in the highest dose group, who took 72mg of CuATSM per day, reported vast improvements in quality of life and symptom severity.

A recent trial of 32 motor neurone disease patients also found CuATSM slowed the progression of the disease and improved cognitive and motor ability.

Ask the expert:

Neurologist Dr Andrew Evans from the Royal Melbourne Hospital:

“The impact has been that (patients) feel better, but also it gives them hope for the future that they are not going to decline in the same way that most patients will do.”

The details:

For more information about clinical trials at The Royal Melbourne Hospital visit www.thermh.org.au/research/clinical-trials

[/vc_column_text][/vc_column][/vc_row]

New Digital Storytelling Platform For Youth Mental Health

[vc_row][vc_column][vc_column_text]Facts and figures:

$2.8 million in funding will be given to the batyr program aiming to further enhance and expand their online presence to support youth mental health and suicide, through safe and effective digital storytelling in schools.

It is estimated one in four young Australians aged 16 to 24 experience mental illness in any given year.

The funding forms part of the $5.3 billion national mental health and suicide prevention plan.

Ask the expert:

Prime Minister Scott Morrison

“This is a program for young people, designed by young people.”

“This will help batyr deliver front-line services and coordinate the right interventions for at-risk young people.”

“Their approach is part of our vision for tackling the mental health challenges facing young Australians and that is a key focus of my government.”

The details:

More information about batyr can be found at www.batyr.com.au/about-us[/vc_column_text][/vc_column][/vc_row]

Australia’s Health System Explained

[vc_row][vc_column][vc_column_text]The World Health Organization describes a good health system as one that ‘delivers quality services to all people, when and where they need them’. In Australia, our health system is best descried as a complex mix of health professionals and service providers from a range of organisations, including government and non-government sectors, working to meet the health care needs of all Australians.

Australia’s health system has multiple components – health promotion, primary health care, specialist services and hospitals. To meet individual health care needs, a person may need – or have to engage with – the services of more than one part of the system.

1. Primary health care

Primary health care is often a person’s first contact with the health system. It comprises a range of services that are not referred: general practice, allied health services, pharmacy and community health. Various health professionals deliver these, including GPs, nurses, allied health professionals, community pharmacists, dentists and ATSI health workers.

2. Specialist services

Specialist services support people with specific or complex health conditions and issues, such as antenatal services for pregnancy, radiotherapy treatment for cancer and mental health services. Specialist services are generally referred by primary health care providers and often described as ‘secondary’ health care services.

3. Hospitals

Hospitals are a crucial part of Australia’s health system, delivering a range of services to admitted and non-admitted patients (outpatient clinics and emergency department care). All public hospitals in Australia are part of a Local Hospital Network.

State and territory governments largely own and manage public hospitals – which usually provide ‘acute care’ for short periods. Private hospitals are mainly owned and operated by either for-profit or not-for-profit organisations.

Australia’s health system may be more accurately described as various connected health systems, rather than one unified system. The Australian Government, state and territory governments and local governments share responsibility for it, including for its operation, management and funding. While the overarching framework for the health system is laid out by government, the private sector also operates and funds some health services. These including operating private hospitals, pharmacies and many medical practices, as well as funding through private health insurance.

Changes to Australia’s Constitution in 1946 allowed the Federal Government to become involved in the funding of public hospital services, resulting in the funding, operational and regulatory arrangements that exist today.

Australia’s health system is underpinned by Medicare – a universal public health insurance scheme. Medicare is funded by the Australian Government through general taxation revenue and a 2% Medicare levy. Intergovernmental arrangements for public hospital funding between the Australian Government and state and territory governments guarantee Medicare cardholders access to fee-free treatment as public patients in public hospitals. Medicare also covers a portion of the Medicare Benefits Schedule fee for medical services and procedures, and Medicare cardholders have access to a range of prescription pharmaceutical subsidies under the Pharmaceutical Benefits Scheme.

Some medical and allied health services are not subsidised through Medicare. For example, Medicare does not usually cover costs for ambulance services, most dental examinations and treatments, physiotherapy and optical aids (such as glasses and contact lenses).

Private health insurance is also an option for meeting health care expenses in Australia. People can choose the type of cover to buy. The two types of cover available are:

  • Hospital cover for some (or all) of the costs of hospital treatments as a private patient;
  • General treatment (‘ancillary’ or ‘extras’) cover for some non-medical health services not covered by Medicare – such as dental, physiotherapy and optical services.

Private health insurance works in tandem with the publicly funded system but does not cover the entirety of a private patient’s costs. Part of the cost of hospital admission as a private patient is covered by Medicare (the medical fee) and part can be covered by insurance.

The Australian Government and state and territory governments are responsible for the regulation of the health system. Various regulatory agencies within the system work to ensure that acceptable standards and quality of care and services are met, and that people are protected when using health goods and services and when dealing with health professionals.

The Australian Government is also responsible for regulating the safety and quality of pharmaceutical and therapeutic goods and appliances. The Therapeutic Goods Administration (TGA) is responsible for regulating therapeutic goods, including prescription medicines, vaccines, sunscreens, vitamins and minerals, and medical devices.

The Australian Government is also responsible for the Prostheses List. The Prostheses List is a list of medical devices that private health insurers are required to pay a benefit for when one of their members has the relevant coverage. For instance, if a member of a health fund has hospital orthopaedic cover and requires a hip replacement, their health fund is required to pay the minimum benefit for any artificial hip listed on the Prostheses List, with generally no out-of-pocket expenses for the patient.

This arrangement ensures surgeons can choose the best available medical device for their privately insured patients without private health insurers restricting their options.

The List is an essential part of the private health insurance offering, enabling Australians with private health insurance to receive the best quality heal care as determined by their doctor, and not by their health insurance provider.

While Australia’s health care system may indeed seem complex and confusing, it is still one of the best health care systems in the world.[/vc_column_text][vc_column_text]

Information in this article has been informed by the Australian Institute of Health and Welfare report, 'Australia's Health 2018'.

[/vc_column_text][/vc_column][/vc_row]

Dr Charlie Teo puts spotlight back on cost of specialists

[vc_row][vc_column][vc_column_text]Dr Teo appeared on the Today show with Georgie Gardner who asked him to explain, if the procedure he was offering was valid, why it was not covered by Medicare through the public system. He went on to explain the breakdown of fees and that private hospitals must make a profit.

What started off as a tweet has quickly grown into a full-blown debate about exorbitantly high surgeons’ fees and costs in the Australian healthcare system more broadly.

Dr Teo’s fees have previously been challenged by insurers and Medicare, according to an industry figure quoted in the Sydney Morning Herald this week.

According to Private Healthcare Australia CEO Rachel David, if a rebate was paid by Medicare, the hospital stay, intensive care and rehabilitation would normally be covered by insurance. “The funds will also pay ‘gap cover’ for the surgeon, assistant and anaesthetist, but this will be nowhere near the six-figure sums charged by Dr Teo as this would put too much pressure on premiums for other members,” said Dr David.

In March of this year, Health Minister Greg Hunt announced that the Federal Government would be launching a website which will list feed and out-of-pocket expenses charged by individual specialists, following a report released by the government revealing concerns over doctors charging patients with hidden fees such as ‘administrative’ or ‘booking’ fees. Minister Hunt said that the website would be aimed at reducing the risk of “bill shock”.

Leanne Well, CEO of the Consumers Health Forum, said that “the challenge now will be to ensure that once it is introduced after consultation with consumers and doctors that all specialists use it.”[/vc_column_text][/vc_column][/vc_row]

3D Printing Is Changing Personalised Medicine, Finds IDTechEx Report

[vc_row][vc_column][vc_column_text]

  • OK, tell me more: A new report published by technology research company IDTechEx shows 3D printing – soon to be an $8.1 billion industry by 2029 – is disrupting the way personalised medicine is provided.

3D printing for the medical and dental industry is helping to cut lead time, reduce waste and offers the opportunity for mass customisation. Imagine having the power to create a custom fit medical device right from your desktop.

  • In our own backyard: In Australia the adoption of 3D printing technology in the health sector is still in the early stages. It’s likely that as personalised medical devices, enabled by technologies such as 3D printing, extend into higher risk medical devices the potential risk for patients will increase. The proposed changes to the current medial device regulatory framework in Australia seeks to ensure adequate regulation of personalised medical devices (including 3D printed devices).

KEY INSIGHT: The report found 3D printing improves surgical standards and improves efficiency, resulting in better outcomes for patients. Customised medical devices can result in better functional and aesthetic outcomes.[/vc_column_text][/vc_column][/vc_row]